Steve J. Cramer
Impact in
- Genetics top 2%
- Virus-based gene therapy research
- Infectious Diseases top 5%
- Viral gastroenteritis research and epidemiology
Papers in
- Genetics 20
- Virus-based gene therapy research 19
-
- Viral Infectious Diseases and Gene Expression in Insects 7
- CRISPR and Genetic Engineering 5
- RNA Interference and Gene Delivery 3
- Pluripotent Stem Cells Research 2
- Co-authors
- Rob C. Hoeben (21 shared papers)Frits J. Fallaux (5 shared papers)H. van Ormondt (5 shared papers)Alex J. van der Eb (4 shared papers)Onno Kranenburg (2 shared papers)Ada Houweling (1 shared paper)Diana J.M. van den Wollenberg (8 shared papers)Pieter van de Putte (1 shared paper)
- Journals
- Gene Therapy (6 papers)Human Gene Therapy (4 papers)Stem Cell Research (2 papers)PLoS ONE (2 papers)Experimental Hematology (1 paper)
- Partner nations
- NetherlandsUnited StatesBelgium
In The Last Decade
Steve J. Cramer
31 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 99
- Genetics 999
- Infectious Diseases 290
- Oncology 335
- Molecular Biology 884
- Biotechnology 100
Countries citing papers authored by Steve J. Cramer
This map shows the geographic impact of Steve J. Cramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve J. Cramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve J. Cramer more than expected).
Fields of papers citing papers by Steve J. Cramer
This network shows the impact of papers produced by Steve J. Cramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve J. Cramer. The network helps show where Steve J. Cramer may publish in the future.
Co-authors
The 25 scholars most cited alongside Steve J. Cramer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 458 | |
| 2 | 1998 | 371 | |
| 3 | 1980 | 130 | |
| 4 | 2004 | 75 | |
| 5 | 1993 | 55 | |
| 6 | 2000 | 49 | |
| 7 | 2012 | 46 | |
| 8 | 1999 | 44 | |
| 9 | 2020 | 39 | |
| 10 | 2008 | 33 | |
| 11 | 1996 | 31 | |
| 12 | 2010 | 26 | |
| 13 | 2008 | 19 | |
| 14 | 2010 | 15 | |
| 15 | 1979 | 15 | |
| 16 | 2006 | 13 | |
| 17 | 1982 | 13 | |
| 18 | 2021 | 11 | |
| 19 | 2012 | 11 | |
| 20 | 2009 | 9 |
About Steve J. Cramer
Steve J. Cramer is a scholar working on Genetics, Molecular Biology, Oncology, Infectious Diseases and Hematology, having authored 31 papers that have together received 1.5k indexed citations. Recurring topics across this work include Virus-based gene therapy research (19 papers), Viral Infectious Diseases and Gene Expression in Insects (7 papers), CAR-T cell therapy research (5 papers), CRISPR and Genetic Engineering (5 papers), Viral gastroenteritis research and epidemiology (4 papers), RNA Interference and Gene Delivery (3 papers), Hemophilia Treatment and Research (2 papers) and Pluripotent Stem Cells Research (2 papers). The work is most often cited by research in Genetics (999 citations), Infectious Diseases (290 citations), Oncology (335 citations), Molecular Biology (884 citations) and Biotechnology (100 citations). Steve J. Cramer has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Rob C. Hoeben, Frits J. Fallaux, H. van Ormondt, Alex J. van der Eb, Onno Kranenburg, Ada Houweling, Diana J.M. van den Wollenberg, Pieter van de Putte, Micheline Giphart-Gassler and A. Bout. Their work appears in journals such as Gene Therapy, Human Gene Therapy, Stem Cell Research, PLoS ONE and Experimental Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.